SCHEMBL9105247

SCHEMBL9105247

NC(=O)CC(CC(N)=O)c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.63
CYP2D6 P10635 2/20 0.62
CYP1A2 P05177 1/20 0.62
PKM P14618 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62
GABBR2 O75899 2/20 0.59
GABBR1 Q9UBS5 2/20 0.59
CYP2C19 P33261 3/20 0.55
SLC6A3 Q01959 3/20 0.50
DRD3 P35462 2/20 0.50
LMNA P02545 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
EDNRB P24530 1/20 0.50
MAPK1 P28482 1/20 0.50
MC4R P32245 1/20 0.50
MC3R P41968 1/20 0.50
DRD2 P14416 1/20 0.50
MAPT P10636 1/20 0.47
ATM Q13315 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27814502 0.94 GABBR2 (0.69) ALDH1A1CYP2D6CYP1A2PKMSMN1; SMN2
SCHEMBL21758203 0.90 ALDH1A1 (0.55) ALDH1A1CYP2D6CYP1A2PKMSMN1; SMN2
SCHEMBL16588649 0.90 ALDH1A1 (0.59) ALDH1A1CYP2D6CYP1A2PKMSMN1; SMN2
SCHEMBL1059563 0.90 CYP2D6 (0.56) ALDH1A1CYP2D6CYP1A2PKMSMN1; SMN2
SCHEMBL8187229 0.90 CYP2D6 (0.56) ALDH1A1CYP2D6CYP1A2PKMSMN1; SMN2
SCHEMBL8192677 0.90 CYP2D6 (0.56) ALDH1A1CYP2D6CYP1A2PKMSMN1; SMN2
SCHEMBL27691658 0.90 GABBR2 (0.75) ALDH1A1CYP2D6CYP1A2PKMSMN1; SMN2
Hydrochloric Acid SCHEMBL3666598 0.89 ALDH1A1 (0.54) ALDH1A1CYP2D6CYP1A2PKMSMN1; SMN2
SCHEMBL7401437 0.88 CYP1A2 (0.55) ALDH1A1CYP2D6CYP1A2PKMSMN1; SMN2
SCHEMBL186239 0.88 ALDH1A1 (0.56) ALDH1A1CYP2D6CYP1A2PKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102753702-B Process for preparing optically active 3-substituted glutaric acid monoamides KANEKA CORP 2015-02-11 CN disclosed
CN-102753702-A Process for preparing optically active 3-substituted glutaric acid monoamides KANEKA CORP 2012-10-24 CN disclosed
EP-2460885-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE 3-SUBSTITUTED GLUTARIC ACID MONOAMIDE Kaneka Corporation (JP) 2012-06-06 EP disclosed
EP-0024776-B1 4-PHENYL AND 5-PHENYL-1,4,5,6-TETRAHYDROPYRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES, AND PROCESS FOR PREPARING SAID DERIVATIVES SYNTEX (U.S.A.) INC. (US) 1984-12-27 EP disclosed
US-4322421-A 4-Phenyl-and 5-phenyl-1,4,5,6-tetrahydro-pyrimidine derivatives SYNTEX (U.S.A.) INC. (US) 1982-03-30 US disclosed
US-4261995-A DISORDERS OF CENTRAL NERVOUS SYSTEM AND CARDIOVASCULAR SYSTEM; HYPOTENSIVE SYNTEX (U.S.A.) INC. (US) 1981-04-14 US disclosed
EP-0024776-A1 4-Phenyl and 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives, pharmaceutical compositions containing said derivatives, and process for preparing said derivatives SYNTEX (U.S.A.) INC. (US) 1981-03-11 EP disclosed